Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 17;16(3):347.
doi: 10.3390/genes16030347.

Mitochondrial DNA Pathogenic Variants in Ophthalmic Diseases: A Review

Affiliations
Review

Mitochondrial DNA Pathogenic Variants in Ophthalmic Diseases: A Review

Khaled K Abu-Amero et al. Genes (Basel). .

Abstract

Mitochondria are vital organelles responsible for ATP production and metabolic regulation, essential for energy-intensive cells such as retinal ganglion cells. Dysfunction in mitochondrial oxidative phosphorylation or mitochondrial DNA (mtDNA) pathogenic variants can disrupt ATP synthesis, cause oxidative stress, and lead to cell death. This has profound implications for tissues such as the retina, optic nerve, and retinal pigment epithelium, which are dependent on robust mitochondrial function. In this review, we provide a comprehensive compilation of pathogenic variants in the mtDNA associated with various ophthalmic diseases, including Leber's hereditary optic neuropathy, chronic progressive external ophthalmoplegia, Leigh syndrome, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, among others. We highlight the genetic variants implicated in these conditions, their pathogenic roles, and the phenotypic consequences of mitochondrial dysfunction in ocular tissues. In addition to well-established mutations, we also discuss the emerging evidence of the role of mtDNA's variants in complex multifactorial diseases, such as non-arteritic anterior ischemic optic neuropathy, primary open-angle glaucoma, and age-related macular degeneration. The review aims to serve as a valuable resource for clinicians and researchers, providing a detailed overview of mtDNA pathogenic variants and their clinical significance in the context of mitochondrial-related eye diseases.

Keywords: DNA pathogenic variant; mitochondria; ophthalmology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

References

    1. Chandel N.S. Mitochondria as Signaling Organelles. BMC Biol. 2014;12:34. doi: 10.1186/1741-7007-12-34. - DOI - PMC - PubMed
    1. Anderson A.J., Jackson T.D., Stroud D.A., Stojanovski D. Mitochondria—Hubs for Regulating Cellular Biochemistry: Emerging Concepts and Networks. Open Biol. 2019;9:190126. doi: 10.1098/rsob.190126. - DOI - PMC - PubMed
    1. Wallace D.C., Fan W., Procaccio V. Mitochondrial Energetics and Therapeutics. Annu. Rev. Pathol. Mech. Dis. 2010;5:297–348. doi: 10.1146/annurev.pathol.4.110807.092314. - DOI - PMC - PubMed
    1. Herbers E., Kekäläinen N.J., Hangas A., Pohjoismäki J.L., Goffart S. Tissue Specific Differences in Mitochondrial DNA Maintenance and Expression. Mitochondrion. 2019;44:85–92. doi: 10.1016/j.mito.2018.01.004. - DOI - PubMed
    1. Stańczyk M., Szubart N., Maslanka R., Zadrag-Tecza R. Mitochondrial Dysfunctions: Genetic and Cellular Implications Revealed by Various Model Organisms. Genes. 2024;15:1153. doi: 10.3390/genes15091153. - DOI - PMC - PubMed

Substances